The molecular pathogenesis of most thyroid cancers involves the constitutive activation of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase/Akt (PI3K/AKT) signaling pathways, which leads to excessive cell growth, proliferation, and survival (4). The gene discussed is PIK3CA; the disease is thyroid gland carcinoma.